Dual Implant Versus Single Implant Distal End of Femur

Sponsor
Mayo Clinic (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06032299
Collaborator
(none)
60
1
2
24
2.5

Study Details

Study Description

Brief Summary

This research study is being conducted to examine the effect of two versus one fixation device for fixation of distal femur fractures.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Single Distal Femur Implant
  • Procedure: Dual Distal Femur Implant
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot for Dual Implant Versus Single Implant Distal End of Femur (pDISIDE Femur)
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Single Distal Femur Implant Group

Subjects will receive one of two types of implants for the distal femur fracture. The single implant will be either a plate and screws or a rod. The type of single implant used will be determined by the surgeon based on the characteristics of the fracture.

Procedure: Single Distal Femur Implant
Single implant constructs will be either a retrograde intramedullary nail with interlocking screws or a single plate and screw construct.

Experimental: Dual Distal Femur Implant Group

Subjects will receive two implants for fixation of the distal femur fracture. The dual implant will be either 2 plates with screws or a plate with screws and a rod. The type of dual implant used will be determined by the surgeon based on the characteristics of the fracture.

Procedure: Dual Distal Femur Implant
Dual implant constructs will either be an intramedullary nail with an additional plate and screw construct or dual (two plates in any orientation) plate and screw construct.

Outcome Measures

Primary Outcome Measures

  1. Number of study-eligible subjects [Baseline]

    Total number of subjects to be enrolled in the study

Secondary Outcome Measures

  1. Operative times [Duration of surgery, approximately 2-4 hours]

    Total recorded amount of time in minutes to complete the surgery

  2. Blood loss [Duration of surgery, approximately 2-4 hours]

    Total amount of surgical blood loss, reported in mL.

  3. Hospitalization days [approximately 2-3 days]

    Total number of days a subject requires hospitalization after surgery

  4. Early post-surgical complications [2 weeks post-surgery]

    Number of subjects to experience VTE, cardiopulmonary, and/or infectious complications after surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Femur fracture distal to the femoral diaphysis.

  • Operative treatment within 72 hours of presenting to the treating hospital.

  • Patient was previously ambulatory.

  • Fracture amendable to either single or dual implant fixation.

  • Informed consent can be obtained from the patient, family member, or power of attorney.

Exclusion Criteria:
  • Associated major lower extremity fracture.

  • Ongoing infection.

  • History of metabolic bone disease (Paget's, etc).

  • Pathologic fracture.

  • Open fracture.

  • Severe cognitive impairment (Six Item Screener with 3 or more errors).

  • Stage 5 Parkinson's disease.

  • Significant femoral bone loss requiring planned staged bone grafting.

  • Vascular injury.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Minnesota Rochester Minnesota United States 55905

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Brandon Yuan, MD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Brandon James Yuan, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT06032299
Other Study ID Numbers:
  • 22-004415
First Posted:
Sep 11, 2023
Last Update Posted:
Sep 11, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 11, 2023